The global polymeric biomaterials market, valued at $69.55 billion in 2024, is projected to grow at a CAGR of 15.86% to reach $267.25 billion by 2034. Growth is fueled by increasing demand in regenerative medicine, orthopedics, and wound care, with Asia-Pacific leading due to healthcare expansion and chronic disease prevalence. Challenges include limited mechanical strength and regulatory hurdles, but innovations like high-performance polymers and 3D printing offer growth opportunities. The market's expansion reflects rising healthcare investments and technological advances in medical applications.
DelveInsight's 2026 report reveals more than 100 drugs in development for age-related macular degeneration (AMD), involving over 90 companies globally. These therapies include novel mechanisms like gene therapy, mitochondrial stabilization, and VEGF ...
The cell and gene therapy contract development and manufacturing organization (CDMO) market is projected to grow at a compound annual growth rate (CAGR) of approximately 24% from 2026 to 2034, reaching a market size of $57.1 billion by 2034. Growth i...
The Law Offices of Frank R. Cruz announced upcoming deadlines for shareholders of BitGo Holdings, Erasca, Nano-X Imaging, and Microsoft to file class action lawsuits. These suits allege that the companies made false or misleading statements and faile...
The global healthcare command centers market, valued at $1.8 billion in 2024, is projected to grow at a CAGR of 10.8% to reach $5.0 billion by 2034. These centers use advanced technologies like AI and IoT to optimize patient flow, bed management, and...
Centrus Energy has signed a Letter of Intent with Oklo Inc. to supply high-assay low-enriched uranium (HALEU) for up to five Aurora reactors, with deliveries expected to start in 2029. This agreement supports the growth of domestic nuclear fuel suppl...
